Phio Pharmaceuticals (PHIO) Short Interest Ratio & Short Volume → Tiny AI projects with huge promise hiding in plain sight … (From Weiss Ratings) (Ad) Free PHIO Stock Alerts $0.80 +0.07 (+9.59%) (As of 05/15/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Phio Pharmaceuticals Short Interest DataCurrent Short Volume184,700 sharesPrevious Short Volume33,800 sharesChange Vs. Previous Month+446.45%Dollar Volume Sold Short$128,735.90Short Interest Ratio / Days to Cover0.4Last Record DateApril 30, 2024Outstanding Shares4,590,000 sharesFloat Size4,520,000 sharesShort Percent of Float4.09%Today's Trading Volume103,899 sharesAverage Trading Volume334,896 sharesToday's Volume Vs. Average31% Short Selling Phio Pharmaceuticals ? Sign up to receive the latest short interest report for Phio Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatPHIO Short Interest Over TimePHIO Days to Cover Over TimePHIO Percentage of Float Shorted Over Time Ad Chaikin AnalyticsThis Wall Street stock prediction just went viralPeople around the world follow 50-year Wall Street veteran Marc Chaikin for his surprisingly accurate stock predictions. And he just issued an urgent WARNING for some of the most popular stocks in U.S. history.Watch just the first 5 minutes of his new prediction Phio Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/2024184,700 shares $128,735.90 +446.5%4.1%0.4 $0.70 4/15/202433,800 shares $22,003.80 +57.9%0.8%0.1 $0.65 3/31/202421,400 shares $14,552.00 -87.9%0.5%0.1 $0.68 3/15/2024176,600 shares $167,593.40 +283.9%7.4%0.6 $0.95 2/29/202446,000 shares $49,680.00 -30.0%1.9%0.1 $1.08 2/15/202465,700 shares $42,705.00 +390.3%2.7%0.1 $0.65 Get the Latest News and Ratings for PHIO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Phio Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 1/31/202413,400 shares $7,959.60 -74.1%0.6%0 $0.59 1/15/202451,800 shares $35,700.56 -66.4%2.2%0.1 $0.69 12/31/2023154,200 shares $117,192.00 +23.8%6.4%0.1 $0.76 12/15/2023124,600 shares $94,696.00 +783.7%5.2%0.1 $0.76 11/30/202314,100 shares $15,418.35 -35.0%0.6%0 $1.09 11/15/202321,700 shares $22,568.00 -35.2%0.9%0 $1.04 10/31/202333,500 shares $41,540.00 -91.2%1.5%0 $1.24 10/15/2023379,900 shares $566,051.00 +1,920.7%17.4%0.4 $1.49 9/30/202318,800 shares $28,388.00 +8.7%0.9%0.8 $1.51 9/15/202317,300 shares $28,545.00 +17.7%0.8%0.6 $1.65 8/31/202314,700 shares $31,311.00 +19.5%0.7%0.5 $2.13 8/15/202312,300 shares $27,675.00 +2.5%0.6%0.2 $2.25 7/31/202312,000 shares $32,040.00 -60.0%0.8%0 $2.67 7/15/202330,000 shares $81,900.00 +18.1%2.0%0.1 $2.73 6/30/202325,400 shares $72,898.00 -71.9%1.7%0 $2.87 6/15/202390,300 shares $295,281.00 -12.6%6.1%0.2 $3.27 5/31/2023103,300 shares $361,550.00 +588.7%7.0%0.2 $3.50 5/15/202315,000 shares $50,550.00 -49.8%1.0%0 $3.37 4/30/202329,900 shares $101,062.00 +116.7%2.7%0.2 $3.38 4/15/202313,800 shares $70,816.08 -25.4%1.2%0.1 $5.13 3/31/202318,500 shares $103,970.00 -39.5%1.7%0.8 $5.62 3/15/202330,600 shares $174,132.36 -30.6%2.8%0.8 $5.69 2/28/202344,100 shares $241,668.00 +3.5%4.1%1.2 $5.48 2/15/202342,600 shares $221,520.00 +27.5%3.9%1.2 $5.20 1/31/202333,400 shares $207,808.12 -91.0%3.0%1.1 $6.22 1/15/2023370,600 shares $199,678.91 +305.9%2.8%1.4 $0.54 12/30/202291,300 shares $33,963.60 +157.2%0.7%0.4 $0.37 12/15/202235,500 shares $12,783.55 +7.3%0.3%0.3 $0.36 11/30/202233,100 shares $13,902.00 -14.7%0.3%0.5 $0.42 11/15/202238,800 shares $17,479.40 -38.1%0.3%0.5 $0.45 10/31/202262,700 shares $36,052.50 -35.6%0.5%0.8 $0.58 10/15/202297,300 shares $54,244.75 +19.2%0.7%1.1 $0.56 9/30/202281,600 shares $46,618.08 -6.5%0.6%0.9 $0.57 9/15/202287,300 shares $64,785.33 +46.7%0.7%0.8 $0.74Healthcare Takes A Big Step Forward With The Help Of AI (Ad)The average doctor can diagnose an illness correctly 50-90% of the time. But one innovative company's medical AI gets it right 92%+.Click here to see why this small company is trusted by the Mayo Clinic PHIO Short Interest - Frequently Asked Questions What is Phio Pharmaceuticals' current short interest? Short interest is the volume of Phio Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of April 30th, investors have sold 184,700 shares of PHIO short. 4.09% of Phio Pharmaceuticals' shares are currently sold short. Learn More on Phio Pharmaceuticals' current short interest. What is a good short interest percentage for Phio Pharmaceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 4.09% of Phio Pharmaceuticals' floating shares are currently sold short. Is Phio Pharmaceuticals' short interest increasing or decreasing? Phio Pharmaceuticals saw a increase in short interest in the month of April. As of April 30th, there was short interest totaling 184,700 shares, an increase of 446.4% from the previous total of 33,800 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Phio Pharmaceuticals' float size? Phio Pharmaceuticals currently has issued a total of 4,590,000 shares. Some of Phio Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Phio Pharmaceuticals currently has a public float of 4,520,000 shares. How does Phio Pharmaceuticals' short interest compare to its competitors? 4.09% of Phio Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Phio Pharmaceuticals: Longeveron Inc. (3.56%), Revelation Biosciences, Inc. (1.09%), Atreca, Inc. (0.37%), Aravive, Inc. (1.81%), CohBar, Inc. (0.59%), Biophytis S.A. (2.62%), GeoVax Labs, Inc. (0.32%), Mustang Bio, Inc. (0.91%), Evoke Pharma, Inc. (0.56%), ZyVersa Therapeutics, Inc. (2.08%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Phio Pharmaceuticals stock? Short selling PHIO is an investing strategy that aims to generate trading profit from Phio Pharmaceuticals as its price is falling. PHIO shares are trading up $0.03 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Phio Pharmaceuticals? A short squeeze for Phio Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of PHIO, which in turn drives the price of the stock up even further. How often is Phio Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including PHIO, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: Longeveron Short Squeeze Revelation Biosciences Short Squeeze Atreca Short Squeeze Aravive Short Squeeze CohBar Short Squeeze Biophytis Short Squeeze GeoVax Labs Short Squeeze Mustang Bio Short Squeeze Evoke Pharma Short Squeeze ZyVersa Therapeutics Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:PHIO) was last updated on 5/16/2024 by MarketBeat.com Staff From Our PartnersHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportAmazon's betting big on this unknown AI companyManward PressThis Wall Street stock prediction just went viralChaikin AnalyticsThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeTop 5 AI Stocks to Buy for 2024Market Moving TrendsTop 5 Tech Stocks to Buy for 2024Daily Market AlertsShocking $16T Elon Musk Crypto LeakCrypto 101 Media